HLA-C and neoplasm: Other approaches that attempt to force presentation of tumor antigens through MHC molecules on APCs have focused on peptide and mRNA-based approaches that use computational methods to deliver antigens that are predicted to bind to and be presented by MHCI and MHCII [70, 71].